These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 30315240)

  • 21. Novel interaction of the Z-DNA binding domain of human ADAR1 with the oncogenic c-Myc promoter G-quadruplex.
    Kang HJ; Le TV; Kim K; Hur J; Kim KK; Park HJ
    J Mol Biol; 2014 Jul; 426(14):2594-604. PubMed ID: 24813121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A short peptide that preferentially binds c-MYC G-quadruplex DNA.
    Minard A; Morgan D; Raguseo F; Di Porzio A; Liano D; Jamieson AG; Di Antonio M
    Chem Commun (Camb); 2020 Aug; 56(63):8940-8943. PubMed ID: 32638724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating Molecular Docking Software for Small Molecule Binding to G-Quadruplex DNA.
    Dickerhoff J; Warnecke KR; Wang K; Deng N; Yang D
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DDX5 helicase resolves G-quadruplex and is involved in
    Wu G; Xing Z; Tran EJ; Yang D
    Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20453-20461. PubMed ID: 31548374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New substituted quinoxalines inhibit triple-negative breast cancer by specifically downregulating the c-MYC transcription.
    Hu MH; Wu TY; Huang Q; Jin G
    Nucleic Acids Res; 2019 Nov; 47(20):10529-10542. PubMed ID: 31584090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spontaneous DNA lesions modulate DNA structural transitions occurring at nuclease hypersensitive element III(1) of the human c-myc proto-oncogene.
    Beckett J; Burns J; Broxson C; Tornaletti S
    Biochemistry; 2012 Jul; 51(26):5257-68. PubMed ID: 22667821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disubstituted 1,8-dipyrazolcarbazole derivatives as a new type of c-myc G-quadruplex binding ligands.
    Chen WJ; Zhou CX; Yao PF; Wang XX; Tan JH; Li D; Ou TM; Gu LQ; Huang ZS
    Bioorg Med Chem; 2012 May; 20(9):2829-36. PubMed ID: 22484007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of clinically used oral antiseptics as quadruplex-binding ligands.
    Calabrese DR; Zlotkowski K; Alden S; Hewitt WM; Connelly CM; Wilson RM; Gaikwad S; Chen L; Guha R; Thomas CJ; Mock BA; Schneekloth JS
    Nucleic Acids Res; 2018 Apr; 46(6):2722-2732. PubMed ID: 29481610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crosstalk between G-Quadruplexes and Dnmt3a-Mediated Methylation of the
    Sergeev AV; Loiko AG; Genatullina AI; Petrov AS; Kubareva EA; Dolinnaya NG; Gromova ES
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent Update on Targeting
    Chaudhuri R; Bhattacharya S; Dash J; Bhattacharya S
    J Med Chem; 2021 Jan; 64(1):42-70. PubMed ID: 33355454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and characterization of nucleolin as a c-myc G-quadruplex-binding protein.
    González V; Guo K; Hurley L; Sun D
    J Biol Chem; 2009 Aug; 284(35):23622-35. PubMed ID: 19581307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The flanking sequence contributes to the immobilisation of spermine at the G-quadruplex in the NHE (nuclease hypersensitivity element) III1 of the c-Myc promoter.
    Keniry MA; Owen EA
    FEBS Lett; 2014 May; 588(10):1949-54. PubMed ID: 24735723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted Downregulation of MYC through G-quadruplex Stabilization by DNAi.
    Psaras AM; Chang KT; Hao T; Brooks TA
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wild-type p53 binds to MYC promoter G-quadruplex.
    Petr M; Helma R; Polášková A; Krejčí A; Dvořáková Z; Kejnovská I; Navrátilová L; Adámik M; Vorlíčková M; Brázdová M
    Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27634752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting specific DNA G-quadruplexes with CRISPR-guided G-quadruplex-binding proteins and ligands.
    Qin G; Liu Z; Yang J; Liao X; Zhao C; Ren J; Qu X
    Nat Cell Biol; 2024 Jul; 26(7):1212-1224. PubMed ID: 38961283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-affinity homologous peptide nucleic acid probes for targeting a quadruplex-forming sequence from a MYC promoter element.
    Roy S; Tanious FA; Wilson WD; Ly DH; Armitage BA
    Biochemistry; 2007 Sep; 46(37):10433-43. PubMed ID: 17718513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of a Family of Genomic Sequences Which Interact Specifically with the c-MYC Promoter to Regulate c-MYC Expression.
    Rezzoug F; Thomas SD; Rouchka EC; Miller DM
    PLoS One; 2016; 11(8):e0161588. PubMed ID: 27551915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nucleic acid clamp-mediated recognition and stabilization of the physiologically relevant MYC promoter G-quadruplex.
    Hao T; Gaerig VC; Brooks TA
    Nucleic Acids Res; 2016 Dec; 44(22):11013-11023. PubMed ID: 27789698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fe
    Malina J; Kostrhunova H; Scott P; Brabec V
    Chemistry; 2021 Aug; 27(45):11682-11692. PubMed ID: 34048082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinguishing G-Quadruplexes Stabilizer and Chaperone for c-
    Zhang Y; Cheng Y; Luo Q; Wu T; Huo J; Yin M; Peng H; Xiao Y; Tong Q; You H
    J Am Chem Soc; 2024 Feb; 146(6):3689-3699. PubMed ID: 38296825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.